Private Equity’s Role in Tackling Global Healthcare Inequalities

Image
  Healthcare inequalities remain a pressing issue worldwide, especially in developing economies like India, where access to quality care is often limited. Private equity firms are emerging as key players in addressing these disparities by providing much-needed capital, fostering innovation, and driving efficiency in healthcare delivery systems. With strategic investments in hospitals, diagnostic centers, telemedicine platforms, and pharmaceutical companies , private equity investment in India like those offered by Quadria Capital is helping bridge the healthcare gap, bringing hope to underserved communities. Understanding Global Healthcare Inequalities Many factors drive inequalities in healthcare, economic disparities, inadequate infrastructure, and a shortage of skilled professionals, to name a few. Moreover, you can find an uneven distribution of healthcare facilities between urban and rural areas and an insufficient focus on preventive care and public health. These challen...

Nuances of Healthcare Business Models in India

While other businesses see ups and downs in investment due to external reasons, the healthcare sector remains intact at any point in time. So, like other industrial sectors such as FMCG, investment in healthcare also allows the investors to get a good return. 

equity funds india


During the lockdown period due to COVID-19, the healthcare sector performed well, although some losses were seen in this sector as well. Experts say that the healthcare sector provides a good opportunity for private equity funds in India

According to industry experts, the first step in investing in any business is to understand the business. The healthcare sector in India is not as complicated to understand as it seems. There are multiple business models within healthcare and the subtlety of each business is different. Hence, you have to pay attention to details before investing. 

Export Branded Generics Market

Most companies in India sell branded generics in India and other developing markets. These products are made by companies that own the brand and promote the product to the customer as well. This is a high return on equity business with very slow growth as the perception of allopathic medicines in India is still growing.

Exports Unbranded Generic Market

Many companies in India manufacture and sell unbranded generics to distributors in different developed countries such as the US, UK, etc. The products are not branded and hence there is no similarity between two manufacturers of the same product. This is a low RoE and highly capital-intensive business that sees bouts of volatility in pricing and volumes.

API Manufacturing

Some companies manufacture API and sell it to formulation manufacturers. API is a key raw material to manufacture formulations. This is a B2B business with varying levels of profitability depending on the product segments a company is functioning in.

Hospitals

Hospitals are generally either multi-specialty or super specialty. Super-specialty businesses can be very profitable if the brand is reputed and its reach is broad. Multi-specialty hospitals are less profitable compared to the former but get higher volumes and easier to scale up.

Comments

Popular posts from this blog

Why Private Equity Firms are Investing in Singapore’s Healthcare Start-ups?

Healthcare Private Equity Investment in Singapore: Trends, Challenges, and Opportunities

Quadria Capital: Powering Better Healthcare through Private Equity Investment